SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-18-004337
Filing Date
2018-04-03
Accepted
2018-04-03 08:52:48
Documents
6
Period of Report
2018-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp89174_8k.htm 8-K 28332
2 EXHIBIT 4.1 dp89174_ex0401.htm EX-4.1 379152
3 EXHIBIT 4.2 dp89174_ex0402.htm EX-4.2 618827
4 EXHIBIT 99.1 dp89174_ex9901.htm EX-99.1 9702
5 EXHIBIT 99.2 dp89174_ex9902.htm EX-99.2 10829
6 GRAPHIC image_001.jpg GRAPHIC 3602
  Complete submission text file 0000950103-18-004337.txt   1053439
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 18731449
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9